Comparison of Cystatin C and Creatinine as Predictors of Cardiovascular Events in a Community-Based Elderly Population

被引:15
|
作者
Beilby, John [1 ,4 ]
Divitini, Mark L. [2 ]
Knuiman, Matthew W. [2 ]
Rossi, Enrico [1 ]
Hung, Joseph [3 ]
机构
[1] Queen Elizabeth II Med Ctr, PathWest, Biochem Sect, Nedlands, WA 6009, Australia
[2] Univ Western Australia, Sch Populat Hlth, Nedlands, WA 6009, Australia
[3] Univ Western Australia, Sch Med & Pharmacol, Sir Charles Gairdner Hosp Unit, Nedlands, WA 6009, Australia
[4] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia
关键词
GLOMERULAR-FILTRATION-RATE; KIDNEY-FUNCTION DECLINE; CORONARY-HEART-DISEASE; RENAL-FUNCTION; OLDER-ADULTS; RISK-FACTOR; SERUM CREATININE; MORTALITY RISK; HEALTH; FAILURE;
D O I
10.1373/clinchem.2009.135962
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
BACKGROUND: Reduced renal function is an established risk factor for cardiovascular events. We compared 3 measures of renal function-serum cystatin C, serum creatinine, and calculated creatinine clearance-as predictors of subsequent cardiovascular events in a community-based population of elderly individuals. METHODS: Comprehensive cardiovascular risk factor data were available for 1410 surviving participants of previous Busselton health surveys who were >= 60 years old. Hazard ratios for risk of incident coronary heart disease and cardiovascular disease over 10 years of follow-up were derived for each baseline measure of renal function by use of Cox regression. RESULTS: All measures of renal function were significantly related to risks of morbidity and mortality from coronary heart disease and cardiovascular disease. There were 453 incident cardiovascular disease events; and the age-and sex-adjusted hazard ratios (95% CIs) were 1.34 (1.23-1.46), 1.32 (1.20-1.45), and 1.22 (1.06-1.41) per 1-SD deterioration in cystatin C, creatinine, and creatinine clearance, respectively. All 3 measures gave approximately the same age-adjusted relative risk estimates. After further adjustment for established cardiovascular risk factors, the relative risk estimates were all reduced but remained statistically significant (P < 0.05). Cystatin C was not a significant predictor for cardiovascular disease after adjustment for creatinine clearance. CONCLUSIONS: In relation to predicting risk for coronary heart disease or cardiovascular disease over a 10 year follow-up in a community-based population of elderly subjects, there was no evidence that cystatin C was a better risk predictor than creatinine or creatinine clearance. (C) 2010 American Association for Clinical Chemistry
引用
收藏
页码:799 / 804
页数:6
相关论文
共 50 条
  • [41] Pretransplantation Cystatin C, but not Creatinine, Predicts 30-day Cardiovascular Events and Mortality in Liver Transplant Recipients With Normal Serum Creatinine Levels
    Kwon, H. -M.
    Moon, Y. -J.
    Jung, K. -W.
    Jun, I. -G.
    Song, J. -G.
    Hwang, G. -S.
    TRANSPLANTATION PROCEEDINGS, 2018, 50 (04) : 1094 - 1099
  • [42] Comparison between creatinine and cystatin C-based GFR equations in renal transplantation
    Zahran, Ahmed
    Qureshi, Mabood
    Shoker, Ahmed
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (09) : 2659 - 2668
  • [43] Estimation of the Age-Dependent Decline of Glomerular Filtration Rate from Formulas Based on Creatinine and Cystatin C in the General Elderly Population
    Christensson, Anders
    Elmstahl, Solve
    NEPHRON CLINICAL PRACTICE, 2011, 117 (01): : C40 - C50
  • [44] Clinical Utility of Creatinine- and Cystatin C-Based Definition of Renal Function for Risk Prediction of Primary Cardiovascular Events in Patients With Diabetes
    Schoettker, Ben
    Herder, Christian
    Mueller, Heiko
    Brenner, Hermann
    Rothenbacher, Dietrich
    DIABETES CARE, 2012, 35 (04) : 879 - 886
  • [45] Comparison of uptake and predictors of adherence in primary and secondary prevention of cardiovascular disease in a community-based cardiovascular prevention programme (MyAction Westminster)
    Murray, Kathryn A.
    Murphy, David J.
    Clements, Sarah-Jane
    Brown, Adrian
    Connolly, Susan B.
    JOURNAL OF PUBLIC HEALTH, 2014, 36 (04) : 644 - 650
  • [46] Comparison of Serum Concentrations of β-Trace Protein, β2-Microglobulin, Cystatin C, and Creatinine in the US Population
    Juraschek, Stephen P.
    Coresh, Josef
    Inker, Lesley A.
    Levey, Andrew S.
    Koettgen, Anna
    Foster, Meredith C.
    Astor, Brad C.
    Eckfeldt, John H.
    Selvin, Elizabeth
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 8 (04): : 584 - 592
  • [47] Lower serum creatinine to cystatin C ratio associated with increased incidence of frailty in community-dwelling elderly men but not in elderly women
    Zhou, Shixian
    Wang, Peixia
    Sun, Linlin
    Zhao, Xinxiu
    Gong, Caixia
    Yang, Yichen
    Ren, Wen
    Yang, Yunmei
    Zhang, Qin
    Jiang, Jingjin
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2024, 36 (01)
  • [48] Serum creatinine to cystatin C ratio is associated with major adverse cardiovascular events in patients with obstructive coronary artery disease
    Lu, Ya-Wen
    Tsai, Yi-Lin
    Chou, Ruey-Hsing
    Kuo, Chin-Sung
    Chang, Chun-Chin
    Huang, Po-Hsun
    Lin, Shing-Jong
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2021, 31 (05) : 1509 - 1515
  • [49] Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
    Chen, Debbie C.
    Lu, Kaiwei
    Scherzer, Rebecca
    Lees, Jennifer S.
    Rutherford, Elaine
    Mark, Patrick B.
    Potok, O. Alison
    Rifkin, Dena E.
    Ix, Joachim H.
    Shlipak, Michael G.
    Estrella, Michelle M.
    KIDNEY MEDICINE, 2024, 6 (04)
  • [50] Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: The Framingham Heart Study
    Fox, CS
    Yang, Q
    Cupples, LA
    Guo, CY
    Larson, MG
    Leip, EP
    Wilson, PWF
    Levy, D
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (09): : 2457 - 2461